Real Estate·Other Specialized REITs·$34.5B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.44 | N/A | -57.03% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.44 | N/A | -57.03% |
| Revenue | N/A | N/A | N/A |
Tone: Defensive
Overall, management acknowledged the difficulties faced in the quarter and emphasized the need for strategic adjustments. They did not provide specific guidance for future performance.
Management expressed concerns about current market conditions impacting performance.
They highlighted ongoing challenges in achieving growth targets.
Iron Mountain's earnings report indicates significant challenges, particularly reflected in the EPS miss. The stock's 8.98% decline suggests investor disappointment and concern over the company's ability to navigate current market conditions. Without any guidance provided, uncertainty remains about future performance and strategic direction.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
VERTEX PHARMACEUTICA
Nov 4, 2024